Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youcef Bagdad

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advances and Applications in Bioinformatics and Chemistry : AABC|December 9, 2024
Recent Applications of Artificial Intelligence in Discovery of New Antibacterial AgentsYoucef Bagdad, Maria A Miteva
Frontiers in Public Health|January 3, 2022
Capturing a Comprehensive Picture of Biological Events From Adverse Outcome Pathways in the Drug ExposomeQier Wu, Youcef Bagdad, Olivier Taboureau, et al.
ACS Omega|October 14, 2024
Machine Learning and Deep Learning Models for Predicting Noncovalent Inhibitors of AmpC β-LactamaseYoucef Bagdad, Marion Sisquellas, Michel Arthur, et al.
Iscience|October 28, 2022
Machine learning and structure-based modeling for the prediction of UDP-glucuronosyltransferase inhibitionBalint Dudas, Youcef Bagdad, Milan Picard, et al.
Chemmedchem|February 13, 2023
Ruthenium-Catalyzed Cycloaddition for Introducing Chemical Diversity in Second-Generation β-Lactamase InhibitorsFlavie Bouchet, Jean-Philippe Barnier, Ines Sayah, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advances and Applications in Bioinformatics and Chemistry : AABC|December 9, 2024
Recent Applications of Artificial Intelligence in Discovery of New Antibacterial AgentsYoucef Bagdad, Maria A Miteva
Frontiers in Public Health|January 3, 2022
Capturing a Comprehensive Picture of Biological Events From Adverse Outcome Pathways in the Drug ExposomeQier Wu, Youcef Bagdad, Olivier Taboureau, et al.
ACS Omega|October 14, 2024
Machine Learning and Deep Learning Models for Predicting Noncovalent Inhibitors of AmpC β-LactamaseYoucef Bagdad, Marion Sisquellas, Michel Arthur, et al.
Iscience|October 28, 2022
Machine learning and structure-based modeling for the prediction of UDP-glucuronosyltransferase inhibitionBalint Dudas, Youcef Bagdad, Milan Picard, et al.
Chemmedchem|February 13, 2023
Ruthenium-Catalyzed Cycloaddition for Introducing Chemical Diversity in Second-Generation β-Lactamase InhibitorsFlavie Bouchet, Jean-Philippe Barnier, Ines Sayah, et al.
Pageof 1